Investing Profile

Keno Gutierrez

InvestorVC
Partner at BGV (BioGeneration Ventures)
biogenerationventures.com/tea...Amsterdam, Netherlands
Photo of Keno Gutierrez, Partner at BGV (BioGeneration Ventures)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
INSEAD Network
203 CONNECTIONS
Piper Jaffray Network
36 CONNECTIONS
M Ventures Network
28 CONNECTIONS
M Ventures Network
28 CONNECTIONS
M Ventures Network
28 CONNECTIONS
cb
$100K - $1M
$500K
10
€250M
CompanyStageDateRound SizeTotal Raised
Dualyx
Series AMay 2023$43M
Series UnknownJan 2020
$43M
FundaMental Pharma
SeedNov 2022$10M
$13M
Co-investors: Mathias Frederiksen (Novartis Venture Fund)
Soteria Biotherapeutics
Series AMay 2021$42M
$42M
Co-investors: David Allison (Westlake Village BioPartners), David Morris (Alex & Thiago)
iOnctura
Series AJul 2020$6M
Series AJan 2020$17M
SeedJun 2017
$110M
Co-investors: Hakan Goker (MDC Ventures (formerly KBS Ventures)), Thijs Cohen Tervaert (INKEF Capital), Roel Bulthuis (Syncona Limited), Fiona MacLaughlin (Johnson & Johnson Innovation JJDC Inc)
ApoGen Biotechnologies
Series AAug 2018$4M
$4M
Inthera Bioscience
Series AJun 2018$5M
Series AMay 2017$11M
$20M
Co-investors: Mark Krul (Aglaia Oncology Funds), Nanna Luneborg (Forbion), Jasper Bos (Forbion)
Chairman of the Board FundaMental Pharma2022 - Present
Observer (former Chairman and Board Member) dualyx2022 - Present
Board Member Stealth mode biotech newco2022 - Present
Board Member Fibrocor Therapeutics2022 - Present
Board Member Stealth mode oncology biotech company2021 - Present
Partner BGV (BioGeneration Ventures)2021 - Present
Board Member Tessellate BIOPresent
Board Member Stealth Company (Keno Gutierrez)Present
Board Member Brenig TherapeuticsPresent
Chairman and Board Member DualyxPresent
Observer (former Chairman and Board Member) DualyxPresent
Chairman DualyxPresent
General Partner BGV (BioGeneration Ventures)Present
CEO and Founder DualyxPresent
Managing Director and Vice President M Ventures2021 - 2021
Board Observer Riffyn2021 - 2021
Board Observer DNA Script2020 - 2021
Board Observer Immunitas Therapeutics2019 - 2021
Board Member and Observer Soteria Biotherapeutics2018 - 2021
Board Member Inthera Bioscience2017 - 2021
Executive Investment Director M Ventures2020 - 2021
Board Member ApoGen Biotechnologies, Inc.2018 - 2021
Board Observer Xilio Therapeutics, Inc.2019 - 2021
Board Member and Observer Galecto Biotech2018 - 2020
Investment Director Healthcare M Ventures2017 - 2020
Board Member iOnctura SA2017 - 2020
Board Observer iOmx Therapeutics AG2018 - 2019
Healthcare Specialist Omega Funds2014 - 2016
Associate - Investment Banking - European Healthcare Piper Jaffray2010 - 2014
Management Consultant IMS Health2006 - 2009
Post-doctoral Research Associate and PhD Researcher Medical Research Council UK2000 - 2006
INSEAD MBA Business
University College London, National Institute for Medical Research Ph.D. Genetics and Lipid Metabolism
National Polytechnic Institute B.Sc (Hons) Pharmaceutical Chemistry
National Polytechnic Institute B.Sc (Hons) Pharmaceutical Chemistry
Sign in with Google →
Sign in with Google →